Evoque and Patisiran: A Tale of Two Regulatory Journeys
Drugs and devices travel different regulatory paths to approval: can evidentiary rigor and regulatory flexibility coexist?
Drugs and devices travel different regulatory paths to approval: can evidentiary rigor and regulatory flexibility coexist?
AbstractAim. The 2021 European Society of Cardiology prevention guidelines recommend the use of (lifetime) risk prediction models to aid decisions regardin
AbstractBackground. Advanced age is associated with an increased risk of adverse cardiovascular events. The relationship between biological age acceleratio
AbstractBackgroundMost patients with atherosclerotic cardiovascular disease (ASCVD) fail to achieve guideline-directed low-density lipoprotein cholesterol (LDL-C) goals. Twice-yearly inclisiran low…
Health authorities are watching for signs the virus might be starting to accelerate again after a springtime lull in COVID rates.
Reducing the levels of triglycerides and triglyceride-rich lipoproteins remains an unmet clinical need. Olezarsen is an antisense oligonucleotide targeting messenger RNA for apolipoprotein C-III (A…
We would like to invite expressions of interest from current BCIS members keen to have a role in the continued development of our Society by…
Patrick Gale is one of this country’s best loved novelists. He has written 20 sparkling books to date. His novels are achingly beautiful. They cover…
This prognostic study assesses the ability of machine learning algorithms to predict outcomes following endovascular intervention for peripheral artery disease (PAD).
The results, which show fewer false positives with the Fetal Medicine Foundation’s model, could promote better prevention.
Despite major advancements in cardiovascular medicine, sudden cardiac death (SCD) continues to be an enormous medical and societal challenge, claiming millions of lives every year.…